NFC Corporation (KOSDAQ:265740)
5,960.00
-140.00 (-2.30%)
At close: May 20, 2026
NFC Corporation Revenue
NFC Corporation had revenue of 9.90B KRW in the quarter ending March 31, 2023, with 35.55% growth. This brings the company's revenue in the last twelve months to 34.07B, down -9.21% year-over-year. In the year 2022, NFC Corporation had annual revenue of 31.48B, down -22.11%.
Revenue (ttm)
34.07B
Revenue Growth
-9.21%
P/S Ratio
3.12
Revenue / Employee
387.21M
Employees
88
Market Cap
106.47B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 31.48B | -8.94B | -22.11% |
| Dec 31, 2021 | 40.41B | 7.09B | 21.28% |
| Dec 31, 2020 | 33.32B | 464.84M | 1.41% |
| Dec 31, 2019 | 32.86B | 8.81B | 36.65% |
| Dec 31, 2018 | 24.05B | 4.46B | 22.80% |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Korea Parts & Fasteners Co.,Ltd | 743.91B |
| Ahn-Gook Pharmaceutical | 306.87B |
| EM-Tech.CO., LTD. | 205.09B |
| PJ Electronics | 178.55B |
| Daebongls.Co.,Ltd. | 102.06B |
| KOREA PHARMA | 87.60B |
| APS Innovation | 73.99B |
| Sewoon Medical | 63.66B |